Henry R. Bourne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henry R. Bourne has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Eric B. Vermillion
Finance Office (Emeritus), University of California, San Francisco, San Francisco, California, USA
1 shared publication
Latest Publications
- Open Access
Lost dollars threaten research in public academic health centers
Decreasing federal and state support threaten long-term sustainability of research in publicly supported academic health centers. In weathering these financial threats, research at the University of California, San Francisco (UCSF) has undergone three substantial changes: (i) institutional salary support goes preferentially to senior faculty, while the young increasingly depend on grants; (ii) private and government support for research grows apace in clinical departments, but slowly declines in basic science departments; and (iii) research is judged more on its quantity (numbers of investigators and federal and private dollars) than on its goals, achievements, or scientific quality. We propose measures to alleviate these problems. Other large public academic health centers probably confront similar issues, but—except for UCSF—such centers have not been subjected to detailed public analysis.
Open AccessLost dollars threaten research in public academic health centers
Decreasing federal and state support threaten long-term sustainability of research in publicly supported academic health centers. In weathering these financial threats, research at the University of California, San Francisco (UCSF) has undergone three substantial changes: (i) institutional salary support goes preferentially to senior faculty, while the young increasingly depend on grants; (ii) private and government support for research grows apace in clinical departments, but slowly declines in basic science departments; and (iii) research is judged more on its quantity (numbers of investigators and federal and private dollars) than on its goals, achievements, or scientific quality. We propose measures to alleviate these problems. Other large public academic health centers probably confront similar issues, but—except for UCSF—such centers have not been subjected to detailed public analysis.
- Open Access
- 21 March 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (13) , 3414-3416
Alfred Gilman: Intrepid, committed scientist
Alfred Gilman died on December 23, 2015, at age 74. With Martin Rodbell, he shared the 1994 Nobel Prize in Physiology or Medicine for discovering the first heterotrimeric guanine-nucleotide-binding (G-) protein and for elucidating the best-understood molecular mechanism for transducing signals across plasma membranes of eukaryotes. Setting a lofty standard for a generation of biomedical scientists, Gilman also served as dean of a medical school, advisor to government and industry, scientific director of a state-sponsored institute for cancer research, and editor of a leading pharmacology textbook. Alfred Gilman. Image courtesy of David Gresham (University of Texas Southwestern, Dallas, TX). Alfred Goodman Gilman was born in 1941, the year his father and Louis S. Goodman produced the first edition of the pharmacology textbook medical students called “Goodman and Gilman.” Young Alfred—born, as he confessed to friends, with a “silver scientific spoon” in his mouth—would become the only scientist ever named for a textbook (1). He majored in biochemistry at Yale, and in 1962 was invited to apply to the MD-PhD program at Case Western Reserve University School of Medicine by one of his father’s friends: Earl Sutherland, who in 1971 would earn a Nobel Prize for discovering cAMP as an intracellular second messenger for hormones. When Gilman arrived at Case, Sutherland was about to move to Vanderbilt, so the budding biochemist joined the laboratory of Ted Rall, who with Sutherland had performed key experiments that led to the cAMP discovery. With Rall, Gilman used an accurate but tedious, labor-intensive assay for cAMP to study thyroid responses to hormonal stimuli. Fresh from his MD-PhD, in 1969 Gilman began postdoctoral training in the NIH laboratory of Marshall Nirenberg, who assigned him to a group focused on development of cultured neurons. Gilman told me a fascinating story about his first paper as a postdoc. …
- 21 March 2016
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (13) , 3414-3416
Open AccessAlfred Gilman: Intrepid, committed scientist
Alfred Gilman died on December 23, 2015, at age 74. With Martin Rodbell, he shared the 1994 Nobel Prize in Physiology or Medicine for discovering the first heterotrimeric guanine-nucleotide-binding (G-) protein and for elucidating the best-understood molecular mechanism for transducing signals across plasma membranes of eukaryotes. Setting a lofty standard for a generation of biomedical scientists, Gilman also served as dean of a medical school, advisor to government and industry, scientific director of a state-sponsored institute for cancer research, and editor of a leading pharmacology textbook. Alfred Gilman. Image courtesy of David Gresham (University of Texas Southwestern, Dallas, TX). Alfred Goodman Gilman was born in 1941, the year his father and Louis S. Goodman produced the first edition of the pharmacology textbook medical students called “Goodman and Gilman.” Young Alfred—born, as he confessed to friends, with a “silver scientific spoon” in his mouth—would become the only scientist ever named for a textbook (1). He majored in biochemistry at Yale, and in 1962 was invited to apply to the MD-PhD program at Case Western Reserve University School of Medicine by one of his father’s friends: Earl Sutherland, who in 1971 would earn a Nobel Prize for discovering cAMP as an intracellular second messenger for hormones. When Gilman arrived at Case, Sutherland was about to move to Vanderbilt, so the budding biochemist joined the laboratory of Ted Rall, who with Sutherland had performed key experiments that led to the cAMP discovery. With Rall, Gilman used an accurate but tedious, labor-intensive assay for cAMP to study thyroid responses to hormonal stimuli. Fresh from his MD-PhD, in 1969 Gilman began postdoctoral training in the NIH laboratory of Marshall Nirenberg, who assigned him to a group focused on development of cultured neurons. Gilman told me a fascinating story about his first paper as a postdoc. …
- Open Access
- 22 January 2015
- Published by Wiley in The FASEB Journal
- Vol. 29 (2) , 357-360
Is 6 Years Too Long to Get a Ph.D. in Biomedical Science?
- 22 January 2015
- Published by Wiley in The FASEB Journal
- Vol. 29 (2) , 357-360
Open AccessIs 6 Years Too Long to Get a Ph.D. in Biomedical Science?
- Open Access
- 1 October 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e01139
A fair deal for PhD students and postdocs
The relentless expansion that threatens the sustainability of biomedical research in the US takes a heavy toll on young researchers.
- 1 October 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e01139
Open AccessA fair deal for PhD students and postdocs
The relentless expansion that threatens the sustainability of biomedical research in the US takes a heavy toll on young researchers.
- Open Access
- 16 July 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e01138
A recipe for mediocrity and disaster, in five axioms
Biomedical research in the US will become unsustainable unless scientists and research institutions start to question certain assumptions they have long taken for granted.
- 16 July 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e01138
Open AccessA recipe for mediocrity and disaster, in five axioms
Biomedical research in the US will become unsustainable unless scientists and research institutions start to question certain assumptions they have long taken for granted.
- Open Access
- 26 March 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e00642
The writing on the wall
The biomedical research enterprise in the US has become unsustainable and urgent action is needed to address a variety of problems, including a lack of innovation, an over-reliance on soft money for faculty salaries, the use of graduate students as a source of cheap labour, and a ‘holding tank’ full of talented postdocs with limited career opportunities.
- 26 March 2013
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 2, e00642
Open AccessThe writing on the wall
The biomedical research enterprise in the US has become unsustainable and urgent action is needed to address a variety of problems, including a lack of innovation, an over-reliance on soft money for faculty salaries, the use of graduate students as a source of cheap labour, and a ‘holding tank’ full of talented postdocs with limited career opportunities.